Trial results for a Community Support Program for Lung Cancer Screening were posted on ClinicalTrials.gov on 2025-09-02, showing that West Philadelphia CSP participants attended 88% of scheduled lung cancer screening appointments.
Background
Lung cancer remains a leading cause of cancer-related mortality globally. Early detection through screening, primarily with low-dose computed tomography (LDCT), has been shown to reduce mortality in high-risk individuals. However, the effectiveness of screening programs relies heavily on consistent patient attendance and adherence to recommended schedules. Various barriers, including socioeconomic factors, lack of awareness, and logistical challenges, can hinder participation in screening programs, particularly in underserved communities. Community-based interventions are often explored as a strategy to overcome these barriers, aiming to improve health behaviors and increase access to preventive care services.
Trial design
This completed study, identified as Phase NA, enrolled 242 participants. The trial focused on individuals with Lung Cancer and those exhibiting specific Behavior patterns related to healthcare engagement. The research aimed to create a program designed to improve attendance for lung cancer screening appointments. The study compared attendance rates among participants in the Community Support Program (CSP) against non-participants and residents from a different area.
Key results
The trial measured the percentage of scheduled lung cancer screening appointments attended by participants across different groups:
- For West Philadelphia CSP Participants, the percentage of scheduled lung cancer screening appointments attended was 88%.
- For West Philadelphia Non CSP Participants, the percentage of scheduled lung cancer screening appointments attended was 68%.
- For Southwest Philadelphia Residents, the percentage of scheduled lung cancer screening appointments attended was 64%.
Additionally, the study reported on the enrollment rate for the Community Support Program:
- The Percentage of CSP Enrollment among West Philadelphia Residents was 14%.
What this means
The posted results indicate that a Community Support Program can substantially improve lung cancer screening attendance. With West Philadelphia CSP Participants showing an 88% attendance rate compared to 68% for non-CSP participants in the same area and 64% for residents in Southwest Philadelphia, the program appears effective in encouraging individuals to attend their scheduled screenings. This suggests that targeted community support interventions can play a vital role in overcoming barriers to preventive care, potentially leading to earlier detection of lung cancer and improved patient outcomes. The 14% enrollment rate among West Philadelphia Residents provides context on the program's reach within that specific population.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT06207435, titled "Community Support Program for Lung Cancer Screening", were posted on 2025-09-02 on clinicaltrials.gov.